Therapeutic Target-Humanized Mice
Cre/Dre-Driver Mice
Immunodeficient NMG Mice
Strain Name：PC-3 Strain State ： Validation of tumorigenic capacity completed | Cat. NO.：NM-Q02
PC-3 is a cell line initiated from a bone metastasis of a grade IV prostatic adenocarcinoma from a 62-year-old, White, male.
Strain Name：MC38-hCD47-hGPC3-Tg Strain State ： Validation of target gene expression completed | Cat. NO.：NMC-230092
CD47 gene humanized mouse cell line of MC38
Strain Name：Kasumi-1 Strain State ： Validation of tumorigenic capacity | Cat. NO.：NM-B13
Human acute myelogenous leukemia cell line
Strain Name：KG-1 Strain State ： Validation of tumorigenic capacity | Cat. NO.：NM-B11
Strain Name：J82 Strain State ： Validation of tumorigenic capacity completed | Cat. NO.：NM-P02A
The malignant human urothelial cell line (J82) was derived from bladder.
Strain Name：MC38-hTNFR2 Strain State ： Validation of tumorigenic capacity completed | Cat. NO.：NMC-230001
TNFRSF1B gene humanized MC38 cell line
Strain Name：MC38-hCD47-Sirpa-KO Strain State ： Validation of target gene expression completed | Cat. NO.：NMC-230060
CD47 gene humanized MC38 cell line with Sirpa gene knockdown
Strain Name：MC38-hCD47/Sirpa Strain State ： Validation of target gene expression completed | Cat. NO.：NMC-230059
CD47 gene humanized MC38 cell line with Sirpa gene overexpression
Strain Name：Hep-2 Strain State ： Validation of tumorigenic capacity | Cat. NO.：NM-Y06
Human laryngeal epidermal carcinoma cell line
Strain Name：OCI-LY3 Strain State ： Validation of tumorigenic capacity | Cat. NO.：NM-B34
Human B cell lymphoma cell line
Please fill in the order form and we will contact you within 2 working days.
